Archives
-
Anti Reverse Cap Analog: Research Context and Evidence
2026-10-06
Anti Reverse Cap Analog (ARCA) is a research reagent intended to model a eukaryotic mRNA 5′ cap while limiting incorrect cap orientation during synthetic RNA production. Its supplier describes potential gains in translation, but the strongest supplied application study—an ACS Nano mouse stroke investigation—supports targeted mRNA delivery rather than ARCA-specific efficacy.
-
METTL16–SENP3–LTF and Ferroptosis in HCC
2026-10-05
Wang et al. identify a METTL16–SENP3–LTF signaling axis that links m6A RNA regulation with iron handling and ferroptosis resistance in hepatocellular carcinoma. The study supports a mechanistic model in which METTL16 promotes tumor progression by stabilizing SENP3-dependent control of lactotransferrin, while also highlighting important limits before this pathway can be translated into clinical intervention.
-
Linezolid and MmpL3 Research: Evidence and Limits
2026-10-04
This overview places Linezolid, an oxazolidinone antimicrobial, alongside emerging spirocyclic POM compounds investigated against Mycobacterium tuberculosis. It compares mechanisms, reported findings, evidence strength, conceptual research uses, and the limits of translating early in vitro results into clinical conclusions.
-
Prenatal Nanoplastics and Vascular Lipid Dysregulation
2026-10-03
A 2026 study links prenatal and lactational exposure to 100-nm polystyrene nanoplastics with vascular lipid accumulation in male mouse offspring and identifies the MAPK/ERK/UHRF1 axis as a candidate mechanism. The findings extend nanoplastic toxicology into early-life vascular biology while remaining limited to a mouse model, cultured vascular smooth muscle cells, and pharmacological and genetic pathway perturbation.
-
D-Luciferin for Reliable Luciferase Assays
2026-10-01
Learn how D-Luciferin, SKU B6040, supports more interpretable ATP-dependent viability assays, promoter-reporter experiments, and bioluminescence imaging workflows. This scenario-based guide connects formulation, controls, optimization, data interpretation, and supplier selection to practical laboratory decisions.
-
Lactylation–NSUN2 Axis in PDAC Perineural Invasion
2026-10-01
This study identifies NSUN2 K692 lactylation as a metabolic-to-epitranscriptomic mechanism that promotes perineural invasion in pancreatic ductal adenocarcinoma. By linking lactate accumulation to m5C-dependent stabilization of CDCP1 and STC1 transcripts, the work provides a mechanistic framework for studying tumor–nerve interactions and potential intervention points.
-
RIPA Lysis Buffer (Medium) for EV Signaling
2026-09-30
RIPA Lysis Buffer (Medium) turns extracellular-vesicle stimulation into reproducible cell and tissue lysates for pathway-focused protein analysis. Its balanced detergent system supports Western blotting and other assays, while careful inhibitor selection and assay-specific optimization help preserve phosphosignals and protein complexes.
-
NHS-Biotin: Practical Protein Biotinylation
2026-09-30
NHS-Biotin (SKU A8002) is an amine-reactive reagent for attaching biotin to accessible lysine side chains and N-terminal amines on antibodies, proteins, and other biomolecules. It is suited to detection, purification, and selected intracellular labeling workflows, but it is not site-specific and requires control of solvent exposure, buffer composition, reagent hydrolysis, and labeling density.
-
Gap19 Workflow for Cx43 Hemichannel Studies
2026-09-29
Gap19 is a selective connexin 43 hemichannel blocker for separating Cx43 hemichannel signaling from gap junction communication. This practical guide covers astrocyte ATP-release assays, macrophage inflammation workflows, ischemia models, dosing logic, and troubleshooting.
-
miR-18a–ALOXE3 Axis in Glioblastoma
2026-09-29
The reference study identifies a miR-18a–ALOXE3 regulatory axis that promotes glioblastoma by weakening p53-SLC7A11-dependent ferroptosis and increasing 12-HETE-driven migration. Its combination of molecular perturbation, lipid mediator analysis, and orthotopic modeling provides a useful framework for connecting lipid metabolism with tumor cell survival and dissemination.
-
Estradiol–Autophagy Axis in Perimenopausal Aging
2026-09-28
A 2026 Life Sciences study integrates NHANES analysis, network pharmacology, and perimenopausal mouse experiments to examine how declining estradiol relates to cardiovascular, renal, and metabolic vulnerability. Its central contribution is evidence that estrogen receptor activity and downstream autophagy jointly reduce fibrosis across the heart, aorta, and kidneys, while also highlighting important limits for translating hormone treatment into clinical practice.
-
Fluorescence-Based mRNA Translation Reporter Assays
2026-09-28
This methods chapter describes GFP- and luciferase-based reporter mRNAs for testing how 5′-UTR sequences influence translation. By transfecting synthetic, capped and polyadenylated mRNA directly into cells, the approach helps isolate translation-related effects from several complications of plasmid-based expression.
-
Hyperthermia–Cisplatin Activates Caspase-8 in Cancer Cells
2026-09-27
A 2024 study finds that hyperthermia combined with cisplatin promotes K63-linked polyubiquitination and accumulation of caspase-8, enhancing both apoptotic and pyroptotic responses in cancer cells. The work links Cullin 3 and p62 to this response and shows why caspase activity measurements are most informative when interpreted alongside genetic and cell-death assays.
-
EZ Cap™ Firefly Luciferase mRNA: Assay Guide
2026-09-26
EZ Cap™ Firefly Luciferase mRNA is a Cap1-capped reporter transcript designed for luciferase expression in delivery, translation, viability, and imaging workflows. Its specifications support experimental planning, while a cited ssDNA-sensing study provides distinct immune-biology context—not evidence about this reporter mRNA.
-
Pam3CSK4 TFA: Interpreting TLR1/2 Responses
2026-09-25
Pam3CSK4 TFA is a defined TLR1/2 agonist for probing how innate immune cells respond to bacterial-lipoprotein signals. This article connects controlled receptor stimulation with recent maternal–newborn cytokine findings—and explains what the results can, and cannot, tell researchers about infection risk.